Volume 13, Issue 1, Pages (January 2012)

Slides:



Advertisements
Similar presentations
Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.
Advertisements

Volume 11, Issue 1, Pages (January 2010)
Volume 14, Issue 12, Pages (December 2013)
Tai Chi Exercise for Cancer-Related Fatigue in Patients With Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial  Li-Li Zhang, RN, Su-Zhen.
Volume 42, Issue 5, Pages (May 2005)
The PSA Era is not Over for Prostate Cancer
Randomization to a low-carbohydrate diet advice improves health related quality of life compared with a low-fat diet at similar weight-loss in Type 2.
The relationship between executive dysfunction, depression, and mental health-related quality of life in survivors of critical illness: Results from the.
Jiaojiao Lü, Lingyan Huang, Xie Wu, Weijie Fu, Yu Liu
Volume 14, Issue 1, Pages (January 2013)
Volume 16, Issue 5, Pages (May 2015)
Awareness of radiation protection and dose levels of imaging procedures among medical students, radiography students, and radiology residents at an academic.
Volume 15, Issue 1, Pages (January 2014)
Volume 30, Issue 1, Pages (January 2014)
Acupuncture versus Sham Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain  Shaun Wen Huey Lee, MPharm, Men Long Liong, MD, Kah Hay Yuen, PhD, Wing.
L. Boyanova  Clinical Microbiology and Infection 
A systematic review and meta-analysis of the accuracy of weight estimation systems used in paediatric emergency care in developing countries  Mike Wells,
F. Chung, R. Subramanyam, P. Liao, E. Sasaki, C. Shapiro, Y. Sun 
American Journal of Kidney Diseases 
Quality-of-life scores in neurogenic thoracic outlet syndrome patients undergoing first rib resection and scalenectomy  Danielle H. Rochlin, BA, Marta.
Tai Chi Exercise for Cancer-Related Fatigue in Patients With Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial  Li-Li Zhang, RN, Su-Zhen.
Efficacy and Safety of a Once-Daily Morphine Formulation in Chronic, Moderate-to- Severe Osteoarthritis Pain  Jacques R. Caldwell, MD, Ronald J. Rapoport,
Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study  Susan R.
Clinical Epidemiology and Global Health
Effect of Electrical Stimulation on Botulinum Toxin A Therapy in Patients With Chronic Myofascial Pain Syndrome: A 16-Week Randomized Double-Blinded Study 
The PSA Era is not Over for Prostate Cancer
Relationship of Problem-Focused Coping Strategies to Changes in Quality of Life Following Treatment for Early Stage Breast Cancer  Sean Ransom, MA, Paul.
Living donor liver transplantation: is the hype over?
Volume 61, Issue 5, Pages (November 2014)
The Impact of Pain Management on Quality of Life
Postoperative pain after abdominal hysterectomy: a randomized, double-blind, controlled trial comparing continuous infusion vs patient-controlled intraperitoneal.
Volume 23, Issue 2, Pages (June 2016)
Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial  Sidney Chocron, MD, PhD, Pierre Vandel, MD, PhD,
Pain in Patients Attending a Specialist Cancer Service: Prevalence and Association With Emotional Distress  Mark O’Connor, MB ChB, Jim Weir, MSc, Isabella.
Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen  Maria-Helena Terrien, MD, François Rahm, MD, Jean-Marc.
Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?  Maura Ravera, Elisabetta.
Open heart surgery: One-Year Self-Assessment of quality of life and functional outcome  Pierre-Emmanuel Falcoz, MD, Sidney Chocron, MD, PhD, Lucian Stoica,
Medicine Based Evidence for Individualized Decision Making: Case Study of Systemic Lupus Erythematosus  Ashley E. Wivel, MD, Kate Lapane, PhD, Christi.
Functional Dyspepsia Is Associated With Sleep Disorders
Samuel J Hassenbusch, MD, PhD, Russell K Portenoy, MD 
Volume 44, Issue 3, Pages (March 2006)
Transdermal Fentanyl for Chronic Pain in AIDS
Issue Highlights Clinical Gastroenterology and Hepatology
Effectiveness of Community-Based Rehabilitation After Traumatic Brain Injury for 489 Program Completers Compared With Those Precipitously Discharged 
Treatment of chronic autoimmune urticaria with omalizumab
Ronnie Fass, Stephen J. Sontag, Barry Traxler, Mark Sostek 
Fatigue and Aging With a Disability
Therapeutic Use of Botulinum Toxin Type A in Treating Neck and Upper-Back Pain of Myofascial Origin: A Pilot Study  Henry L. Lew, MD, PhD, Eun Ha Lee,
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?  François Desgrandchamps  European Urology.
European Urology is “Your” Journal
Clinical Epidemiology and Global Health
Knee arthroscopic surgery is beneficial to middle-aged patients with meniscal symptoms: a prospective, randomised, single-blinded study  H. Gauffin, S.
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
Drug Infusors in Palliative Medicine
Neuropsychological Assessment of Sport-Related Concussion
Randomized trial of balneotherapy associated with patient education in patients with advanced chronic venous insufficiency  Patrick H. Carpentier, MD,
A multicenter randomized controlled trial evaluating balneotherapy in patients with advanced chronic venous insufficiency  Patrick H. Carpentier, MD,
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
The Burden of Stress Urinary Incontinence
Effects of Methylphenidate on Fatigue and Depression: A Randomized, Double-Blind, Placebo-Controlled Trial  Christopher W. Kerr, MD, PhD, Julie Drake,
Volume 373, Issue 9672, Pages (April 2009)
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews  Emily C. Merkel, Sandra A. Mitchell,
Patient-reported outcomes: proportion of patients with clinically meaningful improvements in (A) SF-36 PCS and MCS at Week 52 and Week 104*†‡ and (B) HAQ-DI.
Dennis L. Hart, PhD, PT, Benjamin D. Wright, PhD 
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia  David E. Leaf, David S. Goldfarb  Kidney.
Raban V. Jeger, MD, Peter Rickenbacher, MD, Matthias E
Relationship between clinical classification of chronic venous disease and patient- reported quality of life: results from an international cohort study 
Percentages of patients reporting improvements from baseline ≥minimum clinically important difference (MCID) and number needed to treat (NNT) in (A) patient-reported.
Scott K. Fung, Anna S.F. Lok  Clinical Gastroenterology and Hepatology 
Satisfaction With Activity and Participation and Its Relationships With Body Functions, Activities, or Environmental Factors in Stroke Patients  Édouard.
Presentation transcript:

Volume 13, Issue 1, Pages 43-51 (January 2012) Chronic insomnia, quality-of-life, and utility scores: Comparison with good sleepers in a cross-sectional international survey  Damien Léger, Charles M. Morin, Makoto Uchiyama, Zalmaï Hakimi, Sandrine Cure, James K. Walsh  Sleep Medicine  Volume 13, Issue 1, Pages 43-51 (January 2012) DOI: 10.1016/j.sleep.2011.03.020 Copyright © 2011 Elsevier B.V. Terms and Conditions

Fig. 1 Method of screening respondents based on their Insomnia Severity Index (ISI) score and treatment group. Legend: the Insomnia Severity Index (ISI) score and clinical information were used to identify individuals with chronic insomnia and to assess its severity [22]. The ISI score focuses on both night- and daytime symptoms of insomnia (insomnia severity, worry about sleep, functional impairment, social concern, and sleep satisfaction). It consists of seven questions with scores ranging from 0 to 28 (the maximum score for questions is 4): a score of 0–7 indicates no clinically significant insomnia (i.e., a good sleeper); 8–14, sub-threshold insomnia; 15–21, moderate insomnia; and 22–28, severe insomnia. Exceptionally, we also included in the chronic insomnia groups patients with treated insomnia who had an ISI <7 but who still complained of chronic insomnia according to the definitions for more than 6months. Sleep Medicine 2012 13, 43-51DOI: (10.1016/j.sleep.2011.03.020) Copyright © 2011 Elsevier B.V. Terms and Conditions

Fig. 2 Participant flow in the study. Sleep Medicine 2012 13, 43-51DOI: (10.1016/j.sleep.2011.03.020) Copyright © 2011 Elsevier B.V. Terms and Conditions

Fig. 3 Distribution of the different subscales of the SF-36 for each of the three countries. P-value <.0001 for difference between good sleepers and chronic patients with insomnia in each dimension of SF-36 except where highlighted. Abbreviations: PCS, Physical Component Summary; MCS, Mental Component Summary. Statistically significant P-values for difference between treated and non-treated chronic insomniacs in each dimension of SF-36 are highlighted. Sleep Medicine 2012 13, 43-51DOI: (10.1016/j.sleep.2011.03.020) Copyright © 2011 Elsevier B.V. Terms and Conditions

Fig. 4 Utility scores for good sleepers versus chronic insomniacs and treated versus non-treated chronic insomniacs summarized by country. Sleep Medicine 2012 13, 43-51DOI: (10.1016/j.sleep.2011.03.020) Copyright © 2011 Elsevier B.V. Terms and Conditions